AIManage Using an AI-driven CDS and Chatbot

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT07546357
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Diabetes
  • Medication Side Effects
  • Obesity

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • AIManage — OTHER
    GenAI-powered CDS tool that provides a range of IMM management services, such as personalized guidance for patients on side effects management and clinical advisement to optimize dose titrations.

Study Details

The objective of this project is to define and test the GenAI-powered Clinical Decision Support (CDS) tool, AIManage, providing a broad range of incretin mimetic medication management services to optimize dose titrations. The study will take place across primary care and obesity medicine clinics at NYUH. The study is currently conducting formative data collection for tool refinement (Phase 1). Once completed, a cluster randomized controlled trial of the AIManage tool will be undertaken (Phase 2).

Key Dates

Start date
Jun 1, 2026
Status verified
Apr 2026
Primary completion
Mar 30, 2028
Completion
Mar 30, 2029

Study Design

Enrollment
16 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Providers (Phase 1)
    Providers prescribing IMM for at least 5 adult patients in primary care and obesity medicine clinics.
  • Experimental: Patients (Phase 1)
    Adult patients prescribed an IMM in the past 6 months.

Primary Outcome Measure

Percentage of Patients who Complete Qualitative Measure - Perceived Usefulness [ Time Frame: Day 1 (60 minutes) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016-

Find similar trials in New York, NY

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
NYU Langone Health· New York, NY

Related Studies